GGrantIndex
← Leaderboards

Joanne Wang

University Of Washington

$8,239,883
Attributed
$10,679,014
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,679,014 · 5

By mechanism

R01$7,232,466 · 2
UC2$2,755,586 · 1
R21$690,962 · 2

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Xenobiotics

Research focus

XenobioticsPlayPhysiologicalMediatingPharmaceutical PreparationsCell MembraneIn VivoMolecularBloodCationsMouse ModelBrainSoluteLaboratoriesStructure Of Choroid PlexusDrug UsageMonoamineOrganic Cation TransporterUptakeNeurotoxinsStructureExposure ToSerotoninTissues

Grant awards (29)

Identification, Quantification, and Functional Characterization of Transporters in Human Placenta, Developing Gut and Fetal Brain$921,621
UC2 · FY2025 · HD · contact PI
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk$744,075
R01 · FY2025 · HD
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk$84,143
R01 · FY2025 · HD
Identification, Quantification, and Functional Characterization of Transporters in Human Placenta, Developing Gut and Fetal Brain$912,344
UC2 · FY2024 · HD · contact PI
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk$637,191
R01 · FY2024 · HD
Identification, Quantification, and Functional Characterization of Transporters in Human Placenta, Developing Gut and Fetal Brain$921,621
UC2 · FY2023 · HD · contact PI
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk$657,268
R01 · FY2023 · HD
Drug Transport Mechanisms at the Blood-CSF Barrier and Effect of Aging$190,309
R21 · FY2022 · AG · contact PI
Drug Transport Mechanisms at the Blood-CSF Barrier and Effect of Aging$217,194
R21 · FY2021 · AG · contact PI
The plasma membrane monoamine transporter (PMAT): expression and role in mIBG disposition in neuroblastoma$367,715
R01 · FY2020 · GM · contact PI
The plasma membrane monoamine transporter (PMAT): expression and role in mIBG disposition in neuroblastoma$367,715
R01 · FY2019 · GM · contact PI
The plasma membrane monoamine transporter (PMAT): expression and role in mIBG disposition in neuroblastoma$372,175
R01 · FY2018 · GM · contact PI
The plasma membrane monoamine transporter (PMAT): expression and role in mIBG disposition in neuroblastoma$111,409
R01 · FY2018 · GM · contact PI
The plasma membrane monoamine transporter (PMAT): expression and role in mIBG disposition in neuroblastoma$375,785
R01 · FY2017 · GM · contact PI
Organic Cation Transporter PMAT: Physiological Function and Role in Drug Disposit$318,270
R01 · FY2015 · GM · contact PI
Organic Cation Transporter PMAT: Physiological Function and Role in Drug Disposit$318,270
R01 · FY2014 · GM · contact PI
Organic Cation Transporter PMAT: Physiological Function and Role in Drug Disposit$307,131
R01 · FY2013 · GM · contact PI
Organic Cation Transporter PMAT: Physiological Function and Role in Drug Disposit$318,270
R01 · FY2012 · GM · contact PI
Drug Transport at the CNS Barriers$268,408
R01 · FY2010 · GM · contact PI
Drug Transport at the CNS Barriers$271,449
R01 · FY2009 · GM · contact PI
Drug Transport at the CNS Barriers$220,503
R01 · FY2009 · GM · contact PI
Drug Transport at the CNS Barriers$271,770
R01 · FY2008 · GM · contact PI
Drug Transport at the CNS Barriers$283,267
R01 · FY2007 · GM · contact PI
Nucleobase Transport at the CNS Barriers$216,302
R01 · FY2005 · GM
Nucleobase Transport at the CNS Barriers$228,851
R01 · FY2004 · GM
Salvage Transporter as a Target for Drug Discovery$148,129
R21 · FY2004 · CA
Nucleobase Transport at the CNS Barriers$228,977
R01 · FY2003 · GM
Salvage Transporter as a Target for Drug Discovery$135,330
R21 · FY2003 · CA
Nucleobase Transport at the CNS Barriers$263,522
R01 · FY2002 · GM